KAITLYN ROSALES: Open Payments
NPI 1457877839 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 102 payments from 26 companies in 2025. Trend: 2023 $513 · 2024 $1,258 · 2025 $2,258
Food & beverage: $2,258
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 13 | $262 |
| Medtronic, Inc. | 4 | $222 |
| Amgen Inc. | 7 | $193 |
| Ascendis Pharma Endocrinology Inc | 6 | $192 |
| Lilly USA, LLC | 8 | $165 |
| Tandem Diabetes Care, Inc. | 3 | $162 |
| Novo Nordisk Inc | 13 | $160 |
| Abbott Laboratories | 16 | $154 |
| Boston Scientific Corporation | 1 | $138 |
| ABBVIE INC. | 4 | $70 |
Products named: TWIIST, MINIMED 780G, Yorvipath, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, JARDIANCE, APOLLO ESG System, Rybelsus.
Industry payments across IL — which companies pay providers there.
